Belluscura plc

Equities

BELL

GB00BD3B8Z11

Medical Equipment, Supplies & Distribution

Delayed London S.E. Other stock markets 05:06:49 14/05/2024 pm IST			5-day change	1st Jan Change
10 ^GBX	-2.44%		+24.00%	-56.87%

02/04	Belluscura sees financial hit from delay to closing TMT acquisition	AN
02/04	AIM WINNERS & LOSERS: 88 Energy finds oil at Hickory-1; Redx to delist	AN

Belluscura plc Announces Implementation of Distribution Agreement with Sunset Healthcare Solutions

February 13, 2024 at 12:30 pm IST

Belluscura plc announced a new partnership with Sunset HealthCare Solutions. Under the distribution agreement, Sunset HealthCare will offer the X-PLOR® portable oxygen concentrator to over 1,600 customers. It is intended that the agreement will be extended to also include distribution of the award winning DISCOV-R? POC in Second Quarter 2024 when the product becomes available to Durable Medical Equipment suppliers.

Latest news about Belluscura plc

Belluscura sees financial hit from delay to closing TMT acquisition	02/04	AN
AIM WINNERS & LOSERS: 88 Energy finds oil at Hickory-1; Redx to delist	02/04	AN
Belluscura plc Provides Earnings Guidance for the Full Year 2024	02/04	CI
Belluscura Amasses 98% Stake in TMT Acquisition	11/03	MT
Belluscura plc completed the acquisition of TMT Acquisition Plc.	08/03	CI
TMT Acquisition Delists from London Bourse	07/03	MT
Belluscura to Launch Mandatory Acquisition of Remaining TMT Shares	19/02	MT
FTSE 100 Closes Lower as Equities Slid on U.S. Inflation Data	13/02	DJ
Belluscura Enters Oxygen Concentrator Distribution Deal With US-based Sunset Healthcare	13/02	MT
Belluscura plc Announces Implementation of Distribution Agreement with Sunset Healthcare Solutions	13/02	CI
FTSE 100 Closes Down 0.3% Dragged by Miners, Financial Stocks	09/02	DJ
Belluscura Declares TMT Acquisition Offer Unconditional	09/02	MT
AIM WINNERS & LOSERS: Belluscura shares up as wraps up TMT takeover	09/02	AN
Belluscura rises as TMT Acquisition takeover offer becomes unconditional	09/02	AN
Nexxen expands partnership; Geiger considers listing	09/02	AN
Belluscura Awaits AIM Admission of Shares to Declare TMT Acquisition Unconditional	08/02	MT
Belluscura says all but one condition satisfied for TMT buy	08/02	AN
Belluscura plc completed the acquisition of 89% stake in TMT Acquisition Plc for £4.7 million.	02/02	CI
MicroSalt shares jump after IPO but investor Tekcapital falls	01/02	AN
Tekcapital shares fall but "excited" as MicroSalt completes IPO	01/02	AN
Tekcapital raises GBP570,000 via sale of Belluscura shares	24/01	AN
UK Investment Group Tekcapital Cuts Stake in Medical Device Company Belluscura	24/01	MT
TMT accepts revised offer terms from Belluscura	19/01	AN
K3 Business says cash balances ahead of forecast	21/12	AN
Belluscura Granted Chinese Distribution Approval for Oxygen Concentrator	20/12	MT

Chart Belluscura plc

Duration

Period

More charts

Company Profile

Belluscura PLC is a United Kingdom-based medical device developer company. The Company is focused on developing lightweight and portable oxygen enrichment technology. The Company's product X-PLOR, is a modular portable oxygen concentrator. The X-PLOR is lightweight, specifically designed to replace metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLOR can deliver up to 95% pure oxygen to patients 24 hours a day, seven days a week. The Company is focused on developing medical devices who suffer from chronic lung diseases, such as the Chronic Obstructive Pulmonary Disease (COPD), respiratory distress caused by COVID-19, and many other respiratory disorders. It is also focused on developing, licensing and manufacturing portable oxygen concentrators for use in treating lung diseases with its oxygen platform technologies, to include recreational and industrial oxygen concentrators, wound care devices, drug delivery devices and more.

Sector

Medical Equipment, Supplies & Distribution

Calendar

02/09/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Belluscura plc

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.1287 USD

Average target price

0.4652 USD

Spread / Average Target

+261.57%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
BELLUSCURA PLC	-56.87%	21.23M
ABBOTT LABORATORIES	-4.82%	182B
MEDTRONIC PLC	+1.38%	111B
BECTON, DICKINSON AND COMPANY	-2.82%	68.48B
DEXCOM, INC.	+0.69%	49.69B
CENCORA, INC.	+8.54%	44.46B
HOYA CORPORATION	+2.33%	40.67B
METTLER-TOLEDO INTERNATIONAL, INC.	+20.50%	31.22B
WEST PHARMACEUTICAL SERVICES, INC.	+1.72%	26.09B
TERUMO CORPORATION	+15.30%	25.32B

Other Medical Equipment, Supplies & Distribution